EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Potential Therapeutic Approaches for Chronic Urticaria: Beyond H1-Antihistamines and Biologics

Torsten Zuberbier, Jonny Peter, Petra Staubach, Leena Chularojanamontri, Kanokvalai Kulthanan

The Journal of Allergy and Clinical Immunology: In Practice · 2023-08 · 11 (8) · 2265-2273

DOI: 10.1016/j.jaip.2023.06.027 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2023-08. Verfasst von Torsten Zuberbier und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP…. Hauptthemen laut MEDLINE: Urticaria, Biological Products, Chronic Urticaria. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 163 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic urticaria is a disease that can significantly impact a patient's quality of life and ability to function. There are effective treatment options, such as nonsedating antihistamines or biologics, but some patients do not respond to these therapies, or the therapies are not available or affordable to all patients. This review aims to summarize potential treatment strategies for patients (1) who do not respond to antihistamines and (2) cannot readily access or do not respond to biologics. The review emphasizes the importance of sound clinical practice, including correct diagnosis of chronic urticaria phenotypes, treatment of associated comorbidities, and consideration of add-on pharmacological and nonpharmacological approaches. Although some treatments may lack high-quality evidence, they may still be justifiable in certain cases, provided that there is shared decision-making, regular reassessment, and early recognition of adverse events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UrticariaBiological ProductsChronic UrticariaHumansQuality of LifeChronic DiseaseHistamine H1 AntagonistsHistamine Antagonists

Stichwörter der Autor:innen

Chronic urticariaCurrent management

Substanzen

Biological ProductsHistamine H1 AntagonistsHistamine Antagonists

Autor:innen und Institutionen

  • Institute of Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Allergology and Immunology, Berlin, Germany. Electronic address: to…
  • Division of Allergy and Clinical Immunology, Department of Medicine, University of Cape Town, Cape Town, South Africa; Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa.
  • Department of Dermatology, University Medical Center Mainz, Mainz, Germany.
  • Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Zitieren

APA

Zuberbier, T., Peter, J., Staubach, P., Chularojanamontri, L., & Kulthanan, K. (2023). Potential Therapeutic Approaches for Chronic Urticaria: Beyond H1-Antihistamines and Biologics. The Journal of Allergy and Clinical Immunology: In Practice, 11(8), 2265-2273. https://doi.org/10.1016/j.jaip.2023.06.027

Vancouver

Zuberbier T, Peter J, Staubach P, Chularojanamontri L, Kulthanan K. Potential Therapeutic Approaches for Chronic Urticaria: Beyond H1-Antihistamines and Biologics. The Journal of Allergy and Clinical Immunology: In Practice. 2023;11(8):2265-2273. doi:10.1016/j.jaip.2023.06.027

BibTeX
@article{Zuberbier2023,
  author = {Zuberbier, Torsten and Peter, Jonny and Staubach, Petra and Chularojanamontri, Leena and Kulthanan, Kanokvalai},
  title = {Potential Therapeutic Approaches for Chronic Urticaria: Beyond H1-Antihistamines and Biologics},
  journal = {The Journal of Allergy and Clinical Immunology: In Practice},
  year = {2023},
  volume = {11},
  number = {8},
  pages = {2265--2273},
  doi = {10.1016/j.jaip.2023.06.027}
}
Kostenlos starten →